NIH-funded research R01 grant

Disparities, aging markers, and accelerated heart aging in young cancer survivors

Official title: Role of disparities and aging biomarkers in accelerated cardiac aging among adolescent and young adult cancer survivors

Funded at University of Tx Md Anderson Can Ctr · NIH-11373537 · Data updated 2026-11-12

Researchers will study why some adolescent and young adult cancer survivors develop faster aging of the heart and how this differs across groups, using biomarkers and follow-up data to identify who is at greatest risk.

More Aging research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Tx Md Anderson Can Ctr
NIH-funded
Lab location1 site (Houston, United States)
Project startJuly 10, 2024
Project endJune 30, 2029
Funding year2026
Award (this year)$1,853,125
NIH project number4R01CA285599-03
Project IDNIH-11373537 on NIH RePORTER

Who could benefit from this research

Could help

ADULT-ALIGNED AYA cancer survivors (ages 15-39 at diagnosis) who received cardiotoxic therapy and are available for long-term follow-up.

Less likely to help

Individuals without a history of cardiotoxic cancer treatment or those not in the survivor population may not experience direct benefits.

What this research studies

This project follows adolescents and young adults who have survived cancer to understand why their hearts may age faster after certain treatments. It will look at aging biomarkers and how they relate to heart function over time in up to 1,200 survivors. The study combines clinical assessments, biomarker analyses, and subgroup comparisons to see who is most at risk and why. The goal is to identify early indicators so clinicians can tailor monitoring and interventions for AYAs affected by cardiotoxic cancer therapies.

Why it matters

Potential benefit: If successful, findings could lead to earlier detection and personalized care to prevent heart problems in AYA cancer survivors.

How similar studies have gone: Previous work suggests aging-related cardiovascular changes in cancer survivors; this study extends to a larger, diverse AYA population with biomarker integration.

Where this research is happening

  • University of Tx Md Anderson Can Ctr
    Houston, United States
    Active

Researchers

  • Principal investigator: Hildebrandt, Michelle a T — University of Tx Md Anderson Can Ctr
  • Study coordinator: Hildebrandt, Michelle a T

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.